首页> 外文期刊>Journal of Ophthalmology >Evaluation of the Effectiveness of Surgical Treatment of Malignant Glaucoma in Pseudophakic Eyes through Partial PPV with Establishment of Communication between the Anterior Chamber and the Vitreous Cavity
【24h】

Evaluation of the Effectiveness of Surgical Treatment of Malignant Glaucoma in Pseudophakic Eyes through Partial PPV with Establishment of Communication between the Anterior Chamber and the Vitreous Cavity

机译:通过部分PPV并建立前房与玻璃体腔之间的交流来评估假晶状体眼恶性青光眼的手术效果

获取原文
           

摘要

Purpose. Determination of partial posterior vitrectomy (PPV) in the proposed modification for treatment of malignant glaucoma.Methods. The prospective, consecutive, single-center case series study involved patients in whom symptoms of malignant glaucoma occurred after combined cataract and glaucoma surgery or after glaucoma surgery in pseudophakic eye. When medical and laser treatment were not successful, partial PPV with establishment of communication between the anterior chamber and the vitreous cavity was performed. Efficacy measures were intraocular pressure (IOP) reduction, corrected distance visual acuity (CDVA), AND the number of antiglaucoma medications. Surgical success and occurring complications were also evaluated.Results. The study enrolled 20 eyes of 17 patients. Average IOP was reduced from 30.4 ± 14.2 (SD) mmHg to 14.6 ± 3.2 (SD) mmHg one year after surgery (P<0.00001). A statistically significant reduction of the number of antiglaucoma medications was obtained from 3.3 ± 1.1 (SD) preoperatively to 1.2 ± 1.1 (SD) at the end of follow-up. Statistically significant improvement of CDVA was observed 3, 6, and 12 months after surgery.Conclusions. Partial PPV with establishment of communication between the anterior chamber and the vitreous cavity enables effective IOP control over a 12-month observation; however, in most cases, it is necessary to use antiglaucoma medications for IOP control.
机译:目的。在拟议的修改中确定用于治疗恶性青光眼的部分后玻璃体切除术(PPV)的方法。前瞻性,连续,单中心病例系列研究涉及在白内障合并青光眼手术后或假晶状体眼的青光眼手术后发生恶性青光眼症状的患者。当药物治疗和激光治疗不成功时,进行部分PPV,并在前房和玻璃体腔之间建立连通。疗效指标包括降低眼内压(IOP),校正远视力(CDVA)以及抗青光眼药物的数量。还评估了手术成功率和发生的并发症。该研究招募了17位患者的20只眼睛。术后一年平均IOP从30.4±14.2(SD)mmHg降低至14.6±3.2(SD)mmHg(P <0.00001)。随访结束后,抗青光眼药物的数量从术前的3.3±1.1(SD)降低到1.2±1.1(SD),具有统计学意义上的减少。术后3、6和12个月观察到CDVA有统计学上的显着改善。在前房和玻璃体腔之间建立连通的部分PPV可在12个月的观察中有效控制IOP;但是,在大多数情况下,有必要使用抗青光眼药物进行IOP控制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号